Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-03-03 @ 3:10 PM
Study NCT ID:
NCT02181634
Status:
COMPLETED
Last Update Posted:
2018-10-03
First Post:
2014-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Sponsor:
PrECOG, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-02
First Submit QC Date:
None
Study First Post Date:
2014-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-26
Results First Submit QC Date:
None
Results First Post Date:
2018-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-05
Last Update Post Date:
2018-10-03
Last Update Post Date Type:
ACTUAL